Rimegepant Orally Disintegrating Tablet Now Available for Acute Treatment of Migraine
Biohaven announced that rimegepant is now available for the acute treatment of migraine with or without aura in adults.
Migraine and Headache
People With Migraine Often Present With Metacognitive Dysfunctions
Compared with people without migraine, people with migraine and migraine with medication overuse headache often have deficits in metacognition.
Galcanezumab Is Relatively Safe for Up to 1 Year in Patients With Episodic and Chronic Migraine
Treatment with humanized monoclonal antibody galcanezumab for up to 1 year was safe and tolerable for episodic and chronic migraine prophylaxis.
Migraine Treatment Delivered by Microneedle Patch Under FDA Review
The FDA has accepted for review the New Drug Application (NDA) for Qtrypta™ (M207) (zolmitriptan intracutaneous microneedle system; Zosano Pharma) for the acute treatment of migraine.
FDA Approves Rimegepant ODT for Acute Treatment of Migraine
The Food and Drug Administration has approved Nurtec™ ODT for the acute treatment of migraine with or without aura in adults.
The Impact of Weight Loss on Migraine Characteristics in Patients With Obesity
Among patients with obesity and migraine, weight loss is associated with reduction of migraine frequency, pain severity, and attack duration and disability.
Psoriasis Associated With Increased Risk for Migraine
Researchers analyzed the relationship between migraines and psoriasis in the general US population, using data obtained from the 2003-2004 National Health and Nutrition Examination Survey (NHANES).
Shared Genetic Variants Associated With Migraine and Multiple Sclerosis
Researchers sought to find any genetic variants associated with migraine or MS that could be identified from genome-wide association studies.
Little Evidence to Support Prophylactic Migraine Treatment in Children
There is little evidence supporting the efficacy of prophylactic pharmacologic treatments for pediatric migraine.
Telephone Based Motivational Interviewing May Increase Behavioral Therapy Initiation in Migraine
Telephone-based motivational interviewing may improve a patient’s rate of initiating behavioral therapy for treatment of migraine.
Next post in Migraine and Headache
